ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Silverback Therapeutics Inc

Silverback Therapeutics Inc (SBTX)

5.87
0.00
(0.00%)
Closed January 17 4:00PM
5.87
0.00
( 0.00% )
Pre Market: 7:00PM

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 1.32M20k10k000500k2.07M
Operating Income 27.6M-18.71M-20.6M-17.98M-10.23M-13.19M-15.34M-21.75M
Pre Tax Income 27.24M-14.96M-17.37M-14.87M-7.17M-10.29M-12.52M-19.13M
Net Income 27.24M-14.96M-17.37M-14.87M-7.17M-10.29M-12.52M-19.13M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT 28.57M-14.96M-17.37M-14.87M-7.17M-10.29M-12.52M-19.13M
EBITDA 27.39M-18.69M-20.58M-17.96M-10.21M-13.18M-15.32M-21.73M
Year End December 30 2023 201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00001.32M30k
Operating Income -18.32M-24.07M-32.92M-89.58M-35.52M-67.52M
Pre Tax Income -17.58M-23.97M-32.95M-89.48M-34.68M-54.37M
Net Income -17.58M-23.97M-32.95M-89.48M-34.68M-54.37M
Preferred Dividends 000000
Basic Earnings Per Share (EPS) -26.756-36.095-0.949-2.579-0.967-0.566
EBIT -17.62M-24.07M-32.92M-89.58M-34.54M-54.37M
EBITDA -17.84M-23.52M-32.28M-88.8M-35.2M-67.45M

Your Recent History

Delayed Upgrade Clock